ID: ALA3085151

Max Phase: Preclinical

Molecular Formula: C29H34N4O9

Molecular Weight: 582.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](NC(=O)[C@H](C)NC(=O)c1cccc2c1Oc1c(C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)cccc1C2(C)C)C(=O)O

Standard InChI:  InChI=1S/C29H34N4O9/c1-13(23(34)32-15(3)27(38)39)30-25(36)17-9-7-11-19-21(17)42-22-18(10-8-12-20(22)29(19,5)6)26(37)31-14(2)24(35)33-16(4)28(40)41/h7-16H,1-6H3,(H,30,36)(H,31,37)(H,32,34)(H,33,35)(H,38,39)(H,40,41)/t13-,14-,15-,16-/m0/s1

Standard InChI Key:  QHRORTXZHJRITC-VGWMRTNUSA-N

Associated Targets(non-human)

Trypsin 394 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 582.61Molecular Weight (Monoisotopic): 582.2326AlogP: 1.53#Rotatable Bonds: 10
Polar Surface Area: 200.23Molecular Species: ACIDHBA: 7HBD: 6
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.91CX Basic pKa: CX LogP: 1.35CX LogD: -5.54
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.24Np Likeness Score: -0.02

References

1. Pryor KE, La Clair JJ..  (1999)  A rapid method to identify exo-protease inhibitors.,  (16): [PMID:10476856] [10.1016/s0960-894x(99)00387-x]

Source